Apotex Health Corp (APTX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2026 | 03-2025 | 03-2024 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 149,396 | 136,536 | 150,749 |
| Income taxes - deferred | 146,092 | 158,930 | -8,640 |
| Accounts receivable | 31,398 | -104,970 | -24,054 |
| Other Working Capital | 101,338 | 112,102 | 372,007 |
| Other Operating Activity | 212,734 | 251,816 | 80,838 |
| Operating Cash Flow | $640,958 | $554,414 | $570,900 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -121,063 | -93,578 | -83,255 |
| Net Acquisitions | 0 | -400,477 | -2,585,896 |
| Purchase Sale Intangibles | -60,912 | -150,509 | -28,270 |
| Other Investing Activity | 4,903 | 16,696 | 0 |
| Investing Cash Flow | $-177,072 | $-627,868 | $-2,697,421 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 968,510 | 717,685 | 0 |
| Debt Repayment | -138,531 | -87,203 | -82,939 |
| Common Stock Issued | N/A | N/A | 13,420 |
| Common Stock Repurchased | -140,951 | -745,715 | -200,000 |
| Dividend Paid | -1,109,622 | -163,952 | 0 |
| Other Financing Activity | -62,863 | 0 | -12,147 |
| Financing Cash Flow | $-483,457 | $-279,185 | $-281,666 |
| Exchange Rate Effect | -1,405 | 9,262 | 3,334 |
| Beginning Cash Position | 77,968 | 421,345 | 2,826,198 |
| End Cash Position | 56,992 | 77,968 | 421,345 |
| Net Cash Flow | $-19,571 | $-352,639 | $-2,408,187 |
| Free Cash Flow | |||
| Operating Cash Flow | 640,958 | 554,414 | 570,900 |
| Capital Expenditure | -181,975 | -244,087 | -111,525 |
| Free Cash Flow | 458,983 | 310,327 | 459,375 |